Cytokine Profiling in Chinese SLE Patients: Correlations with Renal Dysfunction

Abstract EN

Background.

Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease that commonly causes kidney damage.

Therefore, we measured plasma levels of cytokines that may be related to renal dysfunction in SLE patients.

Methods.

To explore the differences between SLE patients with renal dysfunction and healthy volunteers, the levels of cytokines in plasma were screened using a human cytokine antibody array.

Then, we chose fourteen of the elevated cytokines for verification with an expanded sample size by a human magnetic Luminex assay.

Plasma samples were isolated from SLE patients (n=72) and healthy volunteers (n=8).

Results.

Cytokine antibody array data showed elevated plasma cytokines in SLE patients with renal dysfunction compared with healthy volunteers.

By using the human magnetic Luminex assay, we found that plasma levels of CHI3L1, GDF-15, IGFBP-2, MIF, ST2, TFF3, and uPAR were significantly higher in SLE patients than in healthy volunteers.

Plasma levels of CXCL4 were significantly lower in the active group than in the inactive group, and plasma levels of CHI3L1, IGFBP-2, MIF, and MPO were significantly higher in the active group than in the inactive group.

We also analyzed the correlation between plasma cytokine levels and the SLEDAI-2K, and our results showed that the plasma levels of the fourteen selected cytokines were weakly correlated or not correlated with the SLEDAI-2K.

We further analyzed the correlation between cytokines and renal dysfunction.

Plasma levels of GDF-15 and TFF3 were highly positively correlated with serum creatinine levels and 24-hour urine protein levels.

Conclusion.

Our data suggest that plasma levels of GDF-15 and TFF3 are potential renal dysfunction markers in SLE patients, but plasma levels of these cytokines are not correlated with the SLEDAI-2K.

Further study is warranted to determine how these cytokines regulate inflammatory responses and renal dysfunction in SLE.